wells pharmacy network tirzepatide Luxe Med | 503A Compounding — Reviews & Licensing Wells Pharmacy Network (@WellsRx) /

Can weight loss reduce breast cancer recurrence

08 Jul Health regulators warn against the use or dispensing of recalled Semaglutide and Tirzepatide Pretoria, 08 July 2026 The South African Pharmacy Council (SAPC), Health Professions Council of South Africa (HPCSA) and the South African Health Products Regulatory Authority (SAHPRA) hereby warn the public, pharmacies and dispensing medical practitioners against any continued use, prescription and/or dispensing of iDEXIS Semaglutide, iDEXIS Tirzepatide, and iDEXIS Semaglutide/Tirzepatide recalled by SAHPRA in June 2026

compounding pharmacies were allowed to create semaglutide-based alternatives , often sold through telehealth platforms such as Hims

By their nature, all forward-looking statements are not guarantees of future performance or results and are subject to risks and uncertainties that are difficult to predict and/or quantify

Poison Control Centers Urge Caution Thinking Ozempic or Wegovy for Weight Loss

Safety is always our first priority at Bodify, a trusted clinic offering Semaglutide for postpartum weight loss